SMT201600348B - Bustina contenente nicotinain forma di sale libero - Google Patents

Bustina contenente nicotinain forma di sale libero

Info

Publication number
SMT201600348B
SMT201600348B SM201600348T SM201600348T SMT201600348B SM T201600348 B SMT201600348 B SM T201600348B SM 201600348 T SM201600348 T SM 201600348T SM 201600348 T SM201600348 T SM 201600348T SM T201600348 B SMT201600348 B SM T201600348B
Authority
SM
San Marino
Prior art keywords
nicotinain
bag containing
free salt
salt
free
Prior art date
Application number
SM201600348T
Other languages
English (en)
Inventor
Per-Gunnar Nilsson
Original Assignee
Nyz Ab
Wm17 Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46888836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600348(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nyz Ab, Wm17 Holding Ag filed Critical Nyz Ab
Publication of SMT201600348B publication Critical patent/SMT201600348B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SM201600348T 2011-03-29 2016-10-04 Bustina contenente nicotinain forma di sale libero SMT201600348B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1150273A SE535587C2 (sv) 2011-03-29 2011-03-29 Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
US201161470264P 2011-03-31 2011-03-31
PCT/SE2012/050336 WO2012134380A1 (en) 2011-03-29 2012-03-28 Pouch containing nicotine in free salt form

Publications (1)

Publication Number Publication Date
SMT201600348B true SMT201600348B (it) 2016-11-10

Family

ID=46888836

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600348T SMT201600348B (it) 2011-03-29 2016-10-04 Bustina contenente nicotinain forma di sale libero

Country Status (20)

Country Link
US (2) US9161908B2 (it)
EP (1) EP2691096B8 (it)
JP (1) JP6047697B2 (it)
KR (1) KR101908157B1 (it)
CN (1) CN103491958B (it)
CA (1) CA2831715C (it)
CY (1) CY1121328T1 (it)
DK (1) DK2691096T3 (it)
ES (1) ES2595158T3 (it)
HR (1) HRP20161228T1 (it)
HU (1) HUE029642T2 (it)
LT (1) LT2691096T (it)
PL (1) PL2691096T3 (it)
PT (1) PT2691096T (it)
RS (1) RS55329B1 (it)
RU (1) RU2608902C2 (it)
SE (1) SE535587C2 (it)
SI (1) SI2691096T1 (it)
SM (1) SMT201600348B (it)
WO (1) WO2012134380A1 (it)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN103261388B (zh) 2010-12-17 2015-12-16 陶氏环球技术有限责任公司 用于在洗衣用洗涤剂中释放香料的乙烯丙烯酸共聚物水分散体
JP5681819B2 (ja) 2011-02-11 2015-03-11 バットマーク・リミテッド 吸入器コンポーネント
SE536491C2 (sv) 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
JP6400678B2 (ja) 2013-05-06 2018-10-03 ジュール・ラブズ・インコーポレイテッドＪｕｕｌ Ｌａｂｓ， Ｉｎｃ． エアロゾル装置用のニコチン塩製剤とその方法
MX2016007283A (es) 2013-12-05 2017-01-06 Pax Labs Inc Formulacion liquida de nicotina para dispositivos en aerosol y metodos de los mismos.
WO2015090337A1 (en) * 2013-12-20 2015-06-25 Fertin Pharma A/S Nicotine powder composition
WO2015193379A1 (en) 2014-06-18 2015-12-23 Swedish Match North Europe Ab A tobacco or non-tobacco product comprising magnesium carbonate
GB201411526D0 (en) * 2014-06-27 2014-08-13 British American Tobacco Co Powder
US11019840B2 (en) 2014-07-02 2021-06-01 R.J. Reynolds Tobacco Company Oral pouch products
US10959456B2 (en) 2014-09-12 2021-03-30 R.J. Reynolds Tobacco Company Nonwoven pouch comprising heat sealable binder fiber
GB201418817D0 (en) 2014-10-22 2014-12-03 British American Tobacco Co Apparatus and method for generating an inhalable medium, and a cartridge for use therewith
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
US20160157515A1 (en) 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
GB201503411D0 (en) 2015-02-27 2015-04-15 British American Tobacco Co Apparatus and method for generating an inhalable medium, and a cartridge for use therewith
CN104824823B (zh) * 2015-03-13 2017-11-28 广东中烟工业有限责任公司 提升再造烟叶感官质量的方法
SE540515C2 (en) * 2015-04-17 2018-09-25 Swedish Match North Europe Ab Oral pouched product having a rectangular shape
USD837447S1 (en) 2015-04-17 2019-01-01 Swedish Match North Europe Ab Oral snuff package
US10327472B2 (en) * 2015-09-25 2019-06-25 Altria Client Services Llc Pre-vaporization formulation for controlling acidity in an e-vaping device
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
SI3383747T1 (sl) * 2015-12-02 2020-06-30 Swedish Match North Europe Ab Postopek za proizvodnjo peroralnega, v vrečkah zapakiranega proizvoda za njuhanje
LT3383203T (lt) 2015-12-02 2020-07-10 Swedish Match North Europe Ab Į maišelius supakuotas per burną vartojamas uostomasis produktas
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
EP3192380B1 (en) 2016-01-12 2020-11-11 Swedish Match North Europe AB Oral pouched product
GB201618481D0 (en) 2016-11-02 2016-12-14 British American Tobacco Investments Ltd Aerosol provision article
WO2018087870A1 (ja) * 2016-11-10 2018-05-17 日本たばこ産業株式会社 球状の粉末凝集体及びその製造方法
EP3330190A1 (en) 2016-12-02 2018-06-06 Swedish Match North Europe AB Method and arrangement for portion-packing of an oral pouched snuff product
PL3614869T3 (pl) 2017-04-24 2025-02-10 Swedish Match North Europe Ab Aromatyzowany wilgotny doustny produkt nikotynowy w saszetce zawierający trójgliceryd
CN107319629A (zh) * 2017-06-16 2017-11-07 云南中烟工业有限责任公司 一种烟碱复合盐袋装口含烟及其制备方法
CN107259635A (zh) * 2017-06-16 2017-10-20 云南中烟工业有限责任公司 一种烟碱复合盐含化片及其制备方法
CN107334179A (zh) * 2017-06-16 2017-11-10 云南中烟工业有限责任公司 一种含烟碱复合盐的胶基型嚼烟及其制备方法
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S Nicotine pouch
CN107536099A (zh) * 2017-09-14 2018-01-05 昌宁德康生物科技（深圳）有限公司 一种尼古丁盐及其制备方法
WO2019110075A1 (en) 2017-12-08 2019-06-13 Fertin Pharma A/S High nicotine concentration
CA3085062C (en) 2017-12-08 2022-08-16 Fertin Pharma A/S Nicotine tablet
CA3085204C (en) 2017-12-15 2023-01-17 Swedish Match North Europe Ab A flavoured moist oral pouched nicotine product comprising monoglyceride
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
GB201812373D0 (en) 2018-07-30 2018-09-12 Nicoventures Trading Ltd Generation of an inhalable medium
GB201812372D0 (en) * 2018-07-30 2018-09-12 Nicoventures Trading Ltd Tobacco blend
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
US10952460B2 (en) * 2018-11-05 2021-03-23 Blesst Boyz LLC Composition for a tobacco-free chew and method of manufacturing same
PH12021551469B1 (en) 2019-02-01 2024-02-07 Swedish Match North Europe Ab AN ORAL NICOTINE PRODUCT COMPRISING A pH ADJUSTING AGENT
SE543560C2 (en) 2019-02-19 2021-03-30 Swedish Match North Europe Ab A packaging material and an oral pouched snuff product
SE542990C2 (en) 2019-03-18 2020-09-22 Swedish Match North Europe Ab A packaging material and an oral pouched nicotine product
US11877590B2 (en) 2019-03-27 2024-01-23 Fiedler & Lundgren Ab Smokeless tobacco composition
DK180339B1 (en) 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
MX2021014974A (es) 2019-06-07 2022-01-24 Philip Morris Products Sa Producto de nicotina en bolsita.
WO2021004928A1 (en) * 2019-07-05 2021-01-14 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
SE1951054A1 (en) * 2019-09-18 2021-03-19 Enorama Pharma Ab Nicotine pouch
EP4356759A3 (en) 2019-11-20 2024-07-03 Swedish Match North Europe AB An oral pouched nicotine product including a filling material comprising nicotine particles
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
EP4072347B1 (en) 2019-12-09 2025-02-12 Nicoventures Trading Limited Fleece for oral product with releasable component
MX2022007086A (es) 2019-12-09 2022-09-09 Nicoventures Trading Ltd Agentes para la composicion oral.
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US12491250B2 (en) 2019-12-09 2025-12-09 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
JP2023505800A (ja) 2019-12-09 2023-02-13 ニコベンチャーズ トレーディング リミテッド 刺激応答性パウチ
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
JP2023504916A (ja) 2019-12-09 2023-02-07 ニコベンチャーズ トレーディング リミテッド ヒートシール可能な結合剤を有するパウチ製品
US20220304921A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Pouched products
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
MX2022006982A (es) 2019-12-09 2022-09-12 Nicoventures Trading Ltd Producto oral en una bolsa porosa que comprende un material de vellon.
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US20210169138A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
CA3160750A1 (en) 2019-12-09 2021-06-17 Anthony Richard Gerardi Oral product comprising a cannabinoid
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
CA3159813A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with dissolvable component
WO2021127101A1 (en) 2019-12-19 2021-06-24 Juul Labs, Inc. Metal oxide-based gel nicotine compositions
KR20220119101A (ko) 2019-12-19 2022-08-26 쥴 랩스, 인크. 유기 기반 니코틴 겔 조성물
US11712059B2 (en) 2020-02-24 2023-08-01 Nicoventures Trading Limited Beaded tobacco material and related method of manufacture
US12016369B2 (en) 2020-04-14 2024-06-25 Nicoventures Trading Limited Regenerated cellulose substrate for aerosol delivery device
WO2021219624A1 (en) * 2020-04-28 2021-11-04 Jt International Sa A nicotine oral delivery product
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
SE545479C2 (en) 2020-06-03 2023-09-26 Swedish Match North Europe Ab A packaging material made of wetlaid nonwoven and a pouched product for oral use
EP4161295A1 (en) 2020-06-08 2023-04-12 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US11382861B1 (en) * 2020-12-17 2022-07-12 Nirajkumar Karneshbhai Patel Nicotine pouch
PL4018846T3 (pl) * 2020-12-22 2024-11-25 Swedish Match North Europe Ab Wyrób w saszetkach do użytku doustnego zawierający materiał pokrywający przepuszczalny dla cieczy oraz materiał wypełniający zawierający cząstki pierwszego rodzaju
PL4018848T3 (pl) * 2020-12-22 2024-11-25 Swedish Match North Europe Ab Wyrób w saszetkach do użytku doustnego zawierający materiał pokrywający przepuszczalny dla cieczy oraz materiał wypełniający
WO2022162558A1 (en) 2021-01-28 2022-08-04 Nicoventures Trading Limited Method for sealing pouches
JP2024510317A (ja) 2021-03-19 2024-03-06 ニコベンチャーズ トレーディング リミテッド エアロゾルデリバリーデバイス用ビーズ状基材
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
EP4094594A1 (en) 2021-05-25 2022-11-30 Consumer Brands International s.r.o. A filing of a nicotine formulation, in particular a nicotine sachet and the method of its manufacture, and a mixture of nicotine salts and the method of its manufacture
EP4094593A1 (en) 2021-05-28 2022-11-30 Swedish Match North Europe AB A flavoured moist oral pouched nicotine product comprising ethyl cellulose
EP4358748A1 (en) 2021-06-25 2024-05-01 Nicoventures Trading Limited Oral products and method of manufacture
CN119789793A (zh) 2021-07-30 2025-04-08 尼科凡图尔斯贸易有限公司 包含微晶纤维素的气溶胶发生基材
WO2023062109A1 (en) 2021-10-13 2023-04-20 Wm19 Holding Ag Oral formulations comprising nicotine salt
JP2024546044A (ja) 2021-11-15 2024-12-17 ニコベンチャーズ トレーディング リミテッド 感覚特性が増強された製品
WO2023089771A1 (ja) * 2021-11-19 2023-05-25 日本たばこ産業株式会社 ニコチン含有組成物におけるニコチン分布の分析方法
EP4193849A1 (en) 2021-12-07 2023-06-14 Swedish Match North Europe AB An oral smokeless product comprising an active agent and/or a flavour
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
DK181550B1 (en) * 2022-01-28 2024-05-02 Mac Baren Tobacco Company As Method for producing a pouch composition
WO2023187225A1 (en) 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products
US20250228770A1 (en) 2022-04-01 2025-07-17 EMPLICURE AB (publ) Alkaline intraoral formulations
CN119212682A (zh) 2022-04-01 2024-12-27 埃姆普里居公司 尼古丁制剂
EP4503974A1 (en) 2022-04-06 2025-02-12 Nicoventures Trading Limited Pouched products with heat sealable binder
EP4256979B1 (en) 2022-04-07 2024-09-11 Swedish Match North Europe AB Pouched product for oral use
CN115119953B (zh) * 2022-06-23 2023-07-14 火柴人(深圳)新材料技术有限责任公司 一种茶叶本草唇烟及其生产工艺
CA3266220A1 (en) * 2022-08-30 2024-03-07 Pocket Tea, Llc SACHET FOR ORAL USE, ADAPTABLE BY THE USER, AND METHOD OF USE
WO2024095163A1 (en) * 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent
CN115989891A (zh) * 2023-02-09 2023-04-21 东莞市吉纯生物技术有限公司 一种尼古丁盐口含制品及其制备方法
DK181726B1 (en) * 2023-04-03 2024-11-08 Fertin Pharma As Pouch with crosslinked alginate
CN120826168A (zh) * 2023-04-07 2025-10-21 日本烟草产业株式会社 用于回收稳定的烟草风味组分的方法和用于生产再生烟草材料的方法
CN116268530A (zh) * 2023-04-12 2023-06-23 东莞市吉纯生物技术有限公司 一种包含ph调节剂包合物的尼古丁口含制品及其制备方法
KR20240157168A (ko) 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법
CN116725219A (zh) * 2023-06-15 2023-09-12 东莞市吉纯生物技术有限公司 一种用于口含制品的缓释型pH调节剂及其应用
WO2025056129A1 (en) * 2023-09-12 2025-03-20 Fertin Pharma A/S Orally disintegrating nicotine tablet for use under lip
US12310395B1 (en) * 2024-05-20 2025-05-27 Jerry Wayne Ross Oral formulations of kava and nicotine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA915648B (en) * 1990-07-23 1992-05-27 Alza Corp Oral osmotic device for delivering nicotine
FR2792200B3 (fr) 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
US8256433B2 (en) * 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
ATE384450T1 (de) * 2001-12-21 2008-02-15 Galenica Ab Tabak und/oder tabak in kombination mit tabakersatz zusammensetzung zur verwendung als schnupf in der mundhöhle
ES2708551T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Material particulado que contiene nicotina con una celulosa cristalina
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
EA012306B1 (ru) 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
CA2537488A1 (en) 2003-09-08 2005-03-17 Pfizer Health Ab Nicotine formulations and use thereof
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
CN101528199B (zh) 2006-03-16 2013-05-29 尼科诺瓦姆股份公司 改良的鼻烟组合物
ES2658166T3 (es) * 2009-03-13 2018-03-08 Excellent Tech Products I Sverige Ab Producto para administración oral
US20110268809A1 (en) * 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive

Also Published As

Publication number Publication date
US20150272878A1 (en) 2015-10-01
CN103491958A (zh) 2014-01-01
WO2012134380A1 (en) 2012-10-04
ES2595158T3 (es) 2016-12-28
LT2691096T (lt) 2016-10-10
HUE029642T2 (en) 2017-02-28
PT2691096T (pt) 2016-10-18
RU2013145288A (ru) 2015-05-10
US9161908B2 (en) 2015-10-20
US20140017286A1 (en) 2014-01-16
SE535587C2 (sv) 2012-10-02
JP6047697B2 (ja) 2016-12-21
US9402810B2 (en) 2016-08-02
EP2691096A1 (en) 2014-02-05
JP2014509645A (ja) 2014-04-21
EP2691096A4 (en) 2014-09-24
PL2691096T3 (pl) 2017-02-28
SI2691096T1 (sl) 2017-01-31
SE1150273A1 (sv) 2012-09-30
CA2831715A1 (en) 2012-10-04
EP2691096B1 (en) 2016-07-13
DK2691096T3 (en) 2016-10-10
CN103491958B (zh) 2017-06-13
RU2608902C2 (ru) 2017-01-26
EP2691096B8 (en) 2016-09-21
CA2831715C (en) 2019-12-31
RS55329B1 (sr) 2017-03-31
HRP20161228T1 (hr) 2016-12-02
KR101908157B1 (ko) 2018-10-15
KR20140050599A (ko) 2014-04-29
CY1121328T1 (el) 2020-05-29

Similar Documents

Publication Publication Date Title
SMT201600348B (it) Bustina contenente nicotinain forma di sale libero
SMT201600184B (it) Sale di meglumina di 6-fluoro-3-idrossi-2-pirazincarbossammide
SMT201600072B (it) Sale sodico di 6-fluoro-3-idrossi-2-pirazina carbossammide
EP2798594A4 (en) VIRTUAL POINT OF SALE
EP2756405A4 (en) PLACING DIRTY AREAS OF NON-VOLATILE MEDIA
UA23573S (uk) Контейнер для косметики
EP2796221A4 (en) PRESSED PRODUCT
UA23450S (uk) Контейнер для косметики
UA23656S (uk) Контейнер
PL2694405T3 (pl) Kontener
UA23291S (uk) Контейнер для косметики
UA24487S (uk) Контейнер для косметики
UA24691S (uk) Контейнер для косметики
EP2668355A4 (en) IMPACT-SAFE CLOSURE
EP2915592A4 (en) APPLIKATORPRODUKT
IL229161A0 (en) Liquid salt cleaning compositions
FR2971776B1 (fr) Conteneur transformable
EP2794530A4 (en) AZEOTROPES OF METHYL CHLORIDE WITH FLUOROCARBONS
UA23655S (uk) Контейнер для косметики
SMT201600474B (it) Procedimento per la preparazione di pemetrexed e suo sale di lisina
GB201208293D0 (en) Hydrochlorice salt of peptide
UA23654S (uk) Контейнер для косметики
FR2974160B1 (fr) Produit isolant
UY4081Q (es) Envase
EP2760804A4 (en) PRODUCT